Abstract
Technological and conceptual advances in the last few years have opened up a variety of new avenues towards improvement of existing vaccines and providing vaccines against diseases for which there is no protection currently available. These new approaches are discussed with particular emphasis on those involving synthetic peptide antigens.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Audibert, F.; Jolivet, M.; Chedid, L.A.; Arnon, R.; and Sela, M. 1982. Successful immunization with a totally synthetic diphtheria vaccine. Proc. Natl. Acad. Sci. USA 79: 5042–5046.
Bittle, J.L.; Houghten, R.A.; Alexander, H.; Shinnick, T.M.; Sutcliffe, J.G.; Lerner R.A.; Rowlands, D.J.; and Brown, F. 1982. Protection against FMD by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 29–8: 30–33.
Both, G.W.; Sleigh, M.J.; Cox, N.J.; and Kendal, A.P. 1983. Antigenic drift in influenza virus H3 haemagglutinin from 1968 to 1980: Multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J. Virol. 48: 52–80.
Buller, R.M.L.; Smith, G.L.; Cremer, K.; Notkins, A.L.; and Moss, B. 1984. Infectious vaccinia virus TK minus hybrid recombinants which express foreign genes are less virulent than wild type virus in BALB/cBYs mice. In Vaccines ’85, eds. R.M. Chanock, R.A. Lerner, and F. Brown, pp. 163–167. New York: Cold Spring Harbor Laboratory.
Cann, A.J.; Stanway, G.; Hughes, P.J.; Minor, P.D.; Evans, D.M.A.; Schild, G.C.; and Almond, J.W. 1984. Reversion to neurovirulence of the live attenuated Sabin type 3 oral poliovirus vaccine. Nucl. Acids Res. 12: 7787–7792.
Chedid, L.A.; Parant, M.A.; Audibert, F.M.; Riveau, G.J.; Parant, F.J.; Lederer, E.; Choay, J.P.; and Lefrancier, P.L. 1982. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect. Immun. 35: 417–424.
Diamond, D.C.; Jameson, B.A.; Emini, E.A.; and Wimmer, E. 1985. Antibody resistant variants of poliovirus type 1. In Vaccines ’85, eds. R.M. Chanock, R.A. Lerner, and F. Brown, pp. 163–167. New York: Cold Spring Harbor Laboratory.
Dreesman, G.R.; Sparrow, J.T.; Kennedy, R.C.; and Melnick, J.L. 1984. Immunogenic and antigenic activities of a cyclic synthetic HBsAg peptide. In Modern Approaches to Vaccines, eds. R.M. Chanock and R.A. Lerner, pp. 115–119. New York: Cold Spring Harbor Laboratory.
Emini, E.A.; Jameson, B.A.; and Wimmer, E. 1983. Priming for and induction of anti poliovirus neutralizing antibodies by synthetic peptides. Nature 304: 699–703.
Ferguson, M.; Evans, D.M.A.; Magrath, D.I.; Minor, P.D.; Almond, J.W.; and Schild, G.C. 1985. Induction by synthetic peptides of broadly reactive, type specific neutralizing antibody to poliovirus type 3. Virology 143: 505–515.
Francis, M.J.; Fry, C.M.; Rowlands, D.J.; Brown, F.; Bittle, J.L.; Houghten, R.A.; and Lerner, R.A. 1985. Priming with peptides of foot and mouth disease virus. In Vaccines ’85, eds. R.M. Chanock, R.A. Lerner, and F. Brown, pp. 203–210. New York: Cold Spring Harbor Laboratory.
Geyson, H.M.; Meloen, R.H.; and Barteling, S.J. 1984. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. USA 81: 3998–4002.
Geyson, H.M.; Barteling, S.J.; and Meloen, R.H. 1985. Small peptides induce antibodies with a sequence and structure requirement for binding antigen comparable to antibodies raised against the native protein. Proc. Natl. Acad. Sci. USA 82: 178–182.
Green, N.; Alexander, H.; Olson, A.; Alexander, S.; Shinnick, T.M.; Sutcliffe, J.G.; and Lerner, R.A. 1982. Immunogenic structure of the influenza virus hemagglutinin. Cell 28: 477–487.
Lerner, R.A. 1982. Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature 299: 592–596.
Makoff, A.J.; Paynter, C.A.; Rowlands, D.J.; and Boothroyd, J.C. 1982. Comparison of the amino acid sequence of the major immunogen from three serotypes of foot and mouth disease virus. Nucl. Acids Res. 10: 8285–8295.
Minor, P.D.; Schild, G.C.; Bootman, J.; Evans, D.M.A.; Ferguson, M.; Reeve, P.; Spitz, M.; Stanway, G.; Cann, A.J.; Hauptmann, R.; Clarke, L.D.; Mountford, R.C.; and Almond, J.N. 1983. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature 301: 674–679.
Muller, G.M.; Shapiro, M.; and Arnon, R. 1982. Anti influenza response achieved by immunization with a synthetic conjugate. Proc. Natl. Acad. Sci. USA 79: 569–573.
Niman, H.L.; Houghten, R.A.; Walker, L.E.; Reisfeld, R.A.; Wilson, I.A.; Hogle, J.M.; and Lerner, R.A. 1983. Generation of protein- reactive antibodies by short peptides is an event of high frequency: Implications for the structural basis of immune recognition. Proc. Natl. Acad. Sci. USA 80: 4949–4953.
Nomato, A.; Omata, T.; Toyoda, H.; Kuge, S.; Hanie, H.; Kataoka, Y.; Genba, Y.; Nakano, Y.; and Imura, N. 1982. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc. Natl. Acad. Sci. USA 79: 5793–5797.
Nunberg, J.H.; Gilbert, J.H.; Rodgers, G.; Snead, R.M.; Nitecki, D.; and Winston, S. 1985. Localization of a determinant of virus neutralization on feline leukaemia virus envelope protein GP70. In Vaccines ’85, eds. R.M. Chanock, R.A. Lerner, and F. Brown, pp. 221–226. New York: Cold Spring Harbor Laboratory.
Pfaff, E.; Mussgay, M.; Bohm, H.O.; Schulz, G.E.; and Schaller, H. 1982. Antibodies against a preselected peptide recognize and neutralize FMDV. EMBO J. 1: 869–874.
Stanway, G.; Hughes, P.J.; Mountford, R.; Reeve, R.; Minor, P.D.; Schild, G.C.; and Almond, J.W. 1984. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a,b. Proc. Natl. Acad. Sci. USA 81: 1539–1540.
Strohmaier, K.; Franze, R.; and Adam, K.-H. 1982. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59: 295–306.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Dr. S. Bernhard, Dahlem Konferenzen, Berlin
About this paper
Cite this paper
Rowlands, D.J. (1986). Vaccines - the Synthetic Antigen Approach. In: Silver, S. (eds) Biotechnology: Potentials and Limitations. Dahlem Workshop Reports, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70535-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-70535-9_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70537-3
Online ISBN: 978-3-642-70535-9
eBook Packages: Springer Book Archive